Reviews of Interest

Reviews of Interest Curated by Dr. Zhian (Anthony) Chen

Photo Credit: Burcu Elmas (pexels.com 10051526) Kidney-Specific Interleukin-17 Responses During Infection and Injury. PMID: 37906942 Peroumal D, Biswas PS. Annu Rev Immunol. 2024 Jun;42(1):35-55. doi: 10.1146/annurev-immunol-052523-015141. Epub 2024 Jun 14.PMID: 37906942 Free article. Review. T Follicular Helper Cell Heterogeneity. PMID: 38060987 Song W, Craft J. Annu Rev Immunol. 2024 Jun;42(1):127-152. doi: 10.1146/annurev-immunol-090222-102834. Epub [READ MORE]

Banner image for FOCiS 2025
Other Meetings

FOCiS 2025 Annual Meeting is June 24 – 27 in Boston, Massachusetts

The Federation of Clinical Immunology Societies (FOCIS) is holding its 25th Annual Meeting, FOCIS 2025 in Boston, Massachusetts. The meeting will take place, in person, June 24-27, 2025, at the Boston Marriott Copley Place. Abstract submission is currently open. Registration and hotel accommodation will open soon. For regular updates, please [READ MORE]

Prof. You-Me Kim, Ph.D
Society News

Honoring Service and Welcoming New Opportunities: Thank You to Professor You-Me Kim

Turnover on governing councils is vital to the health and growth of not-for-profit organizations, bringing fresh ideas, new perspectives, and expanded networks. It’s a best practice embraced by over 85% of nonprofit boards. Yet, as effective as it is, turnover is often bittersweet. With this in mind, ICIS extends heartfelt [READ MORE]

Members Networking
Featured Article!

ICIS Year in Review: Celebrating a Year of Growth and Impact

As we reflect on the past year, we are deeply grateful for your membership and the vibrant community it sustains. The annual ICIS business meeting was held on November 21, 2024, via Zoom. If you were unable to participate, the recorded meeting is now available on-demand. [READ MORE]

Photo of the 2024 award winners in Seoul, Korea
Awards

Recognizing Excellence: ICIS Celebrates the 2024 Award Winners

The International Cytokine & Interferon Society (ICIS) is proud to honor outstanding contributions to the field of cytokine and interferon research through its comprehensive awards program. Designed to recognize excellence at every stage of a scientist’s career, the ICIS awards underscore the Society’s commitment to fostering innovation, mentorship, and impactful [READ MORE]

Image of stacked magazines with title, "Article of Interest"
Reviews of Interest

Don’t Eat Me: Overcoming a Tumor’s Immunosuppressive Microenvironment

Targeting EGFRvIII and CD47-SIRPα: A New CAR-T Strategy for Glioblastoma Treatment Review contributed by: PhD candidate Eugenio Contreras Castillo (one of the 2024 ICIS-Pfizer Trainee Award Winners for Most Promising Research Presentations at Cytokines 2024), Department of Cell Biology Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM) [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials – updated November 20, 2024

1) Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis (ClinicalTrials.gov ID NCT05309616) | 2) Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital (ClinicalTrials.gov ID NCT05835050) | 3)Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc) (ClinicalTrials.gov ID NCT05080790) [READ MORE]

Image of Howard Young titled: From Howard's Desk
From Howard's Desk

Advice From the World of a Science Retiree

By Howard Young, Retired Principal Investigator, National Cancer Institute, Frederick, Maryland, USA Having been retired for 10 months, I thought I would provide a bit of advice of what to expect in retirement for someone who had a scientific career. Drs. Sharon Wahl and Charlie Glinka contributed some thoughts to [READ MORE]

ICIS President and President-Elect, Sarah Gaffen and Curt Horvath in front of Gang Nam hands, Seoul, Korea
Featured Article!

Cytokines2024 Rocks, Gang Nam Style

There’s no doubt, Cytokines2024 in Seoul, Korea was a resounding success. The ICIS/KAI joint meeting boasted nearly 2,000 attendees from 36 countries, 55 invited speakers, 55 pharma and vendor sponsors, > 600 posters, 20 junior and senior research awards, 47 ICIS travel awards, and a Nobel Laureate. The conference was [READ MORE]